[ad_1]
Nifty futures on the Singapore Stock Exchange were down 52.5 points, or 0.28 percent, at 18,615.5, indicating that Dalal Street is off to a negative start on Friday.
PNB/UTI AMC: Punjab National Bank (PNB) on Thursday said it has received government approval to divest its entire stake (15.22 per cent) in UTI Asset Management Company as part of its non-core sale plan to raise capital the last of us. base Read here
SBI: State Bank of India (SBI), the country’s largest lender, plans to raise Rs 10,000 crore in infrastructure loans in the current financial year. Read more
HDFC Bank: The private sector lender has decided to elevate Kaizad Bharucha as deputy managing director and appoint Bhavesh Zaveri to the board as whole-time managing director. Read more
India’s Tube Investments: The Murugappa Group has acquired a 50 percent stake in X2Fuels and Energy, an early-stage startup housed at the National Center for Combustion Research and Development (NCCRD) at IIT Madras. Read here
Oil Corporation of India: ICICI Bank, Prudential ICICI Life Insurance, HDFC Life Insurance and SBI Life Insurance have entered into agreements to invest in the seed capital of a proposed joint venture of Oil Corporation of India and Chennai Oil Corporation. The project is expected to see an investment of Rs 31,580 crore.
TVS Motor: The company expanded its global footprint and opened its first showroom in Singapore.
Tata Steel Long: The company has acquired a further 46.87 million shares at a premium of Rs 54 per share from Neelachal Ispat Nigam for Rs 300 million (tranche 2).
PVR: PVR has opened 12 superlex screens in Thiruvananthapuram, Kerala.
Lupin: The US FDA has issued Form-483 with eight observations each for the drug product entity and the API entity of the company’s Mandideep-1 unit.
West Coast Paper Mills: ICRA has revised the long-term rating to AA.
Veranda Learning Solutions: The company has partnered with IIM Raipur and SHRM (Society for Human Resource Management) to launch a Post Graduate Business Program (online MBA) in HR Management.
Biocon: Major biotechnology company Biocon Biologics as part of a legal transaction to buy the biologics business of Viatris Inc. In February, Biocon Biologics signed a deal to value Viatris Inc’s biosimilars business for about $3.34 billion.
Statement:Disclaimer: The opinions and investment tips of the experts in this report are those of News18.com and not those of the website or its management. Users are advised to check with certified professionals before taking any investment decision.
Read all the Latest Business News here
[ad_2]
Source link
